Is there a case for PSA screening, after all?

Recommendations against prostate cancer screening may need to be revised after a reanalysis of the evidence found prostate-specific antigen (PSA) testing significantly reduces mortality.

However, questions remain about how to implement screening so the benefits outweigh the potential harms of overdiagnosis and overtreatment.